CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
What’s at Stake: Sites Aren’t Neutral for Kids
Proposed changes to site-neutral payments would threaten children’s health care.
Oct. 08, 2026
Putting Children’s Health on the Agenda at AAP
CHA joined pediatric leaders from across the country to advance shared priorities and keep children’s unique health needs at the center of national conversations.
Oct. 07, 2026
New Poll Shows Strong Bipartisan Support for Children’s Health
Parents are united on key policy priorities for pediatric health care.
Oct. 05, 2026
